Lactobacillus reuteri CF48-3A BEI HM-102
Microbe ID: PMDBM281
Microbe Name: Lactobacillus reuteri CF48-3A BEI HM-102
Taxonomy Level: Strain
NCBI Taxonomy ID:
525341
Taxonomy Genus: Lactobacillus [1578]
Taxonomy Family: Lactobacillaceae [33958]
Microbe Alteration of Therapeutic Substances| Substance Name | Substance Category | Substance Subcategory | Metabolism Type | Metabolites | Effects on Substance | Experimental System | Experimental Organism | Experimental Disease Condition | Alteration Mechanism | Alteration Outcome | Reference (PubMed ID) |
|---|
| Substance Name | Substance Category | Substance Subcategory | Substance Details | Effect on Microbe | Effect Strength | Experimental System | Experimental Organism | Experimental Disease Condition | Reference (PubMed ID) |
|---|
Microbe Alteration of Herbal Substances| Substance Name | Substance Category | Substance Subcategory | Metabolism Type | Metabolites | Effects on Substance | Experimental System | Experimental Organism | Experimental Disease Condition | Alteration Mechanism | Alteration Outcome | Reference (PubMed ID) |
|---|
| Substance Name | Substance Category | Substance Subcategory | Substance Details | Effect on Microbe | Effect Strength | Experimental System | Experimental Organism | Experimental Disease Condition | Reference (PubMed ID) |
|---|
Dietary Substance Alteration of Microbe| Substance Name | Substance Category | Substance Subcategory | Substance Details | Effect on Microbe | Effect Strength | Experimental System | Experimental Organism | Experimental Disease Condition | Reference (PubMed ID) |
|---|
Microbe Alteration of Environmental Substances| Substance Name | Substance Category | Substance Subcategory | Metabolism Type | Metabolites | Effects on Substance | Experimental System | Experimental Organism | Experimental Disease Condition | Alteration Mechanism | Alteration Outcome | Reference (PubMed ID) |
|---|
| Substance Name | Substance Category | Substance Subcategory | Substance Details | Effect on Microbe | Effect Strength | Experimental System | Experimental Organism | Experimental Disease Condition | Reference (PubMed ID) |
|---|
Diseases Associated with the Alteration of Microbiota Composition| Microbiota Site | Disease Name | Disease Association Class | Disease Associated Abundence Change | Reference (PubMed ID) |
|---|
Landscape of Bacteria-Substance-Disease Interaction/Association Network
The substances in "Bacteria-Substance-Disease Interaction/Association network" only cover therapeutic drugs. The network is presented for an intuitive visualization of the drugs that interact with microbiota bacteria, diseases that associated with microbiota bacteria changes, and disease-drug interactions. The interactive network is generated using Cytoscape.js.
Relative abundance landscape of Lactobacillus reuteri CF48-3A BEI HM-102 in human gut microbiota samples
The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].
Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients’ country, or disease type to plot the relative abundance landscape using ggplot2 R package.